MYDOCALM MYDOCALM MYDOCALM

Dose: 100 mg
Single Dose: 100 (100)
Frequency: 12 hourly
Route: IM
Instructions:

Dose: 1.66 to 3.33 mg/kg
Single Dose: 2.5 (2.495)
Frequency: 8 hourly
Route: Oral
Instructions:

Dose: 0.66 to 1.33 mg/kg
Single Dose: 1 (0.995)
Frequency: 8 hourly
Route: Oral
Instructions: Dose for above 6 Yrs of children

belongs to Piperidinopropiophenone. It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Gastrointestinal Anticholinergics/Antispasmodics pharmacological group.The Molecular Weight of Tolperisone (HCl) is 281.80.

Tolperisone (HCl) is contraindicated in conditions like Myasthenia gravis.

The symptomatic adverse reactions produced by Tolperisone (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Muscle weakness, SomnolenceX.

Tolperisone (HCl) is primarily indicated in conditions like Muscular hypertension, Obliterative vascular disease.

No data regarding the interactions of Tolperisone (HCl) was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

During tolperisone administration it should be decided after careful risk benefit evaluation wether use the preparation, particularly in the first three month of pregnancy.